This is an innovative high-risk, high-reward funded project. The goal is to develop a novel RNA strategy that targets Tau to revert Alzheimer’s disease (also applicable to other diseases). The position requires extensive RNA manipulation. If successful, high impact publications and patents are expected as well as extension of funding. The project is a collaboration between the University of Seville (Spain), the Autonomous University of Madrid (Spain), and the University of California, San Diego (USA). Contract: 2 years. Location: School of Pharmacy (University of Seville) and/or SOM (Autonomous University of Madrid). Interested candidates should send their CV by e-mail to Albert Garcia (AlbertGQ1970@us.es) before October 30, 2022. Please, wri
This job listing is no longer active.
Check the left side of the screen for similar opportunities.